Onconetix's Acquired Realbotix Unit Launches UK Pilot for Humanoid Robots in Elderly Care
ONCO sits 20% above its 52-week low of $0.88.
Summary
Onconetix's acquisition target, Realbotix LLC, has partnered with Bloom Services to launch a UK pilot program deploying humanoid robots to combat elderly social isolation. This partnership also accredits Realbotix as a supplier on Bloom's public sector marketplace, opening a new market for the robotics technology. This positive business development for the acquired entity comes as Onconetix navigates significant financial challenges, including a going concern warning and substantial share dilution from recent equity line draws. The acquisition of Realbotix is expected to close in the second half of 2026, subject to shareholder and regulatory approvals.
At the time of this announcement, ONCO was trading at $1.06 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $0.88 to $270.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.